Stock analysts at Leerink Partnrs lifted their Q4 2025 earnings per share (EPS) estimates for shares of Illumina in a ...

Illumina (ILMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

As America's population ages and some state populations are expected to decline, demographic shifts may profoundly reshape the country's colleges and universities. Academics have long worried ...

Illumina raises Q4 and FY24 revenue outlook, expects solid margins, with projected 2024 EPS between $4.12 and $4.14.

Stock analysts at Leerink Partnrs increased their FY2024 earnings estimates for Illumina in a research report issued to clients and investors on Tuesday, January 21st. Leerink Partnrs analyst P. Souda ...

Most adults (94%) believe some kind of postsecondary degree or certificate is valuable, according to a 2024 Gallup and Lumina Foundation report. However, the report found significant barriers to ...

Illumina Inc (ILMN) stock saw a modest uptick, ending the day at $144.22 which represents a slight increase of $7.53 or 5.51% from the prior close of $136.69. The stock opened at $137 and touched a ...

Citigroup has recently reduced Illumina Inc (ILMN) stock to Neutral rating, as announced on December 11, 2024, according to Finviz. Earlier, on November 12, 2024, Morgan Stanley had resumed the stock ...

The renowned medical device company has a market capitalization of $15.94 billion. ALGN’s earnings ... the company successfully launched the iTero Lumina intraoral scanner, its next generation ...